WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian LianPresident CEO2024-03-01162,815$85.22
$13.88MSell
Marianna ManciniChief Operating Officer2024-03-0116,958$85.22
$1.45MSell
Greg ZanteChief Financial Officer2024-03-0120,093$85.22
$1.71MSell
Brian LianPresident CEO2024-02-0945,000$29.90
$1.35MSell
Brian LianPresident CEO2024-02-0849,079$1.23
$60.37kBuy
Brian LianPresident CEO2024-02-0840,000$27.45
$1.10MSell
Brian LianPresident CEO2024-02-0860,000$25.95
$1.56MSell
Brian LianPresident CEO2024-02-08140,000$4.65
$651.00kBuy
Brian LianPresident CEO2024-02-0849,079$25.75
$1.26MSell
Sarah Kathryn RouanDirector2024-02-0825,000$28.05
$701.25kSell

1 of 8

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.93%15,004,340$1.21BInstitution
Blackrock Inc7.57%7,605,867$614.78MInstitution
Ligand Pharmaceuticals Inc5.79%5,819,383$470.38MInsider
State Street Corp5.71%5,732,990$463.40MInstitution
Vanguard Group Inc5.36%5,381,904$435.02MInstitution
Viking Global Investors LP5.12%5,145,112$415.88MInstitution
Alliancebernstein LP3.66%3,673,935$296.96MInstitution
Balyasny Asset Management LP2.23%2,243,523$181.34MInstitution
American Century Companies Inc2.21%2,223,822$179.75MInstitution
Brian Lian2.19%2,198,734$177.72MInsider

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX75.97%9.83%Net SellingNet Selling
ASND100.00%0.00%
ROIV40.20%59.80%Net SellingNet Selling
CERE26.91%73.09%Net BuyingNet Selling
JAZZ26.94%73.06%Net SellingNet Selling

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 75.97% institutional shareholders, 9.83% Viking Therapeutics insiders, and 14.20% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.79% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $484.99M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.